PharmaSync

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

PharmaSync - overview

Established

2012

Location

Milwaukie, OR, US

Primary Industry

Pharmaceuticals

About

PharmaSync is a company that focuses on delivering innovative solutions to enhance operational efficiency across various sectors, including healthcare, finance, and logistics, streamlining processes and improving data management. Founded in 2012 and headquartered in Milwaukie, US, PharmaSync specializes in developing solutions tailored for the healthcare, finance, and logistics industries. The company underwent an acquisition by Triton Pacific Capital Partners in May 2012, which aimed to accelerate its growth. The founder's history is not specified.


PharmaSync specializes in providing a comprehensive suite of innovative solutions designed to address specific challenges in healthcare, finance, and logistics. Its products enhance operational efficiency, improve data management, and foster communication among clients ranging from small startups to large enterprises. The company markets its offerings primarily in North America and Europe, catering to businesses seeking to modernize their operations. PharmaSync generates revenue through a mix of subscription-based services and direct sales.


Clients typically enter into annual subscription agreements for the company's flagship products, which include ongoing updates and support. Additionally, partnerships with industry-specific retailers enhance market reach. This revenue model emphasizes long-term client relationships, securing multi-year agreements to facilitate smoother integration into clients' operations. PharmaSync plans to leverage its acquisition by Triton Pacific Capital Partners to accelerate growth.


The company is focusing on the development of new products aimed at enhancing existing services, with expected rollouts in the near future. Furthermore, it aims to expand into additional markets across Europe and Asia by 2023, which will be funded through the growth strategy established during its recent acquisition.


Current Investors

Triton Pacific Capital Partners

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.pharma-sync.com

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

PharmaSync - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedPharmaSync-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.